Nestle India Ltd (NESTLEIND) Q1 FY27 Results Analysis: PAT Jumps 47.9%, EBITDA Margin Expands 253 bps

Nestle India Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 6,378.20 Cr (+25.20% YoY) and PAT growth of +47.90% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Nestlé India reported a strong Q1 with 25.2% revenue growth and 253 bps EBITDA margin expansion, driven by volume-led growth, rural momentum, and cost management. PAT grew 47.9% YoY. The company demonstrated pricing power and procurement efficiency despite input cost pressures. Key watch items are the elevated advertising spend and widening associate losses from the health science JV.

Key Investment Insights

Key Positives

• Revenue grew 25.2% YoY to Rs.6,378.2 Cr, led by volume growth across all product groups.
• EBITDA margin expanded 253 bps YoY to 24.12%, driven by 214 bps improvement in cost of materials as a percentage of sales.
• PAT grew 47.9% YoY to Rs.975.1 Cr, with operating leverage nearly doubling revenue growth into profit growth.
• Rural markets led the momentum, contradicting expectations of rural softening.
• Cost of materials as a percentage of sales improved to 42.86% from 45.00% despite input cost inflation, demonstrating pricing power and procurement efficiencies.
• Exports grew 35.6% YoY, significantly outpacing domestic sales growth of 25.0%.

Risk Factors

• Other expenses grew 29.0% YoY, outpacing revenue growth, partly due to a 40%+ increase in advertising spends.
• Associate loss (Dr. Reddy's and Nestle Health Science JV) widened to Rs.16.4 Cr from Rs.12.6 Cr a year ago, as the venture scales.